ID   LAT2_RAT                Reviewed;         533 AA.
AC   Q9WVR6;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   24-JUL-2024, entry version 156.
DE   RecName: Full=Large neutral amino acids transporter small subunit 2;
DE   AltName: Full=L-type amino acid transporter 2;
DE   AltName: Full=Solute carrier family 7 member 8;
GN   Name=Slc7a8; Synonyms=Lat2, Lat4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBUNIT, TISSUE SPECIFICITY, AND ACTIVITY REGULATION.
RC   TISSUE=Small intestine;
RX   PubMed=10391916; DOI=10.1074/jbc.274.28.19745;
RA   Segawa H., Fukasawa Y., Miyamoto K., Takeda E., Endou H., Kanai Y.;
RT   "Identification and functional characterization of a Na+-independent
RT   neutral amino acid transporter with broad substrate selectivity.";
RL   J. Biol. Chem. 274:19745-19751(1999).
RN   [2]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16027961; DOI=10.1007/s00726-005-0221-x;
RA   Fraga S., Pinho M.J., Soares-da-Silva P.;
RT   "Expression of LAT1 and LAT2 amino acid transporters in human and rat
RT   intestinal epithelial cells.";
RL   Amino Acids 29:229-233(2005).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=15980244; DOI=10.1167/iovs.04-1175;
RA   Tomi M., Mori M., Tachikawa M., Katayama K., Terasaki T., Hosoya K.;
RT   "L-type amino acid transporter 1-mediated L-leucine transport at the inner
RT   blood-retinal barrier.";
RL   Invest. Ophthalmol. Vis. Sci. 46:2522-2530(2005).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-29; SER-30 AND
RP   SER-529, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15200428; DOI=10.1111/j.1523-1755.2004.00722.x;
RA   Pinho M.J., Serrao M.P., Gomes P., Hopfer U., Jose P.A.,
RA   Soares-da-Silva P.;
RT   "Over-expression of renal LAT1 and LAT2 and enhanced L-DOPA uptake in SHR
RT   immortalized renal proximal tubular cells.";
RL   Kidney Int. 66:216-226(2004).
CC   -!- FUNCTION: Associates with SLC3A2 to form a functional heterodimeric
CC       complex that translocates small and large neutral amino acids with
CC       broad specificity and a stoichiometry of 1:1 (PubMed:10391916).
CC       Functions as amino acid antiporter mediating the influx of
CC       extracellular essential amino acids mainly in exchange with the efflux
CC       of highly concentrated intracellular amino acids. Has relatively
CC       symmetrical selectivities but strongly asymmetrical substrate
CC       affinities at both the intracellular and extracellular sides of the
CC       transporter. This asymmetry allows SLC7A8 to regulate intracellular
CC       amino acid pools (mM concentrations) by exchange with external amino
CC       acids (uM concentration range), equilibrating the relative
CC       concentrations of different amino acids across the plasma membrane
CC       instead of mediating their net uptake. May play an essential role in
CC       the reabsorption of neutral amino acids from the epithelial cells to
CC       the bloodstream in the kidney. Involved in the uptake of methylmercury
CC       (MeHg) when administered as the L-cysteine or D,L-homocysteine
CC       complexes, and hence plays a role in metal ion homeostasis and
CC       toxicity. Involved in the cellular activity of small molecular weight
CC       nitrosothiols, via the stereoselective transport of L-nitrosocysteine
CC       (L-CNSO) across the transmembrane (By similarity). Imports the thyroid
CC       hormone diiodothyronine (T2) and to a smaller extent triiodothyronine
CC       (T3) but not rT 3 or thyroxine (T4) (By similarity). Mediates the
CC       uptake of L-DOPA (PubMed:15200428). May participate in auditory
CC       function (By similarity). {ECO:0000250|UniProtKB:Q9QXW9,
CC       ECO:0000250|UniProtKB:Q9UHI5, ECO:0000269|PubMed:10391916,
CC       ECO:0000269|PubMed:15200428}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-dopa(out) + L-phenylalanine(in) = L-dopa(in) + L-
CC         phenylalanine(out); Xref=Rhea:RHEA:71439, ChEBI:CHEBI:57504,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000305|PubMed:15200428};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3,3'-diiodo-L-thyronine(out) = 3,3'-diiodo-L-thyronine(in);
CC         Xref=Rhea:RHEA:71823, ChEBI:CHEBI:176514;
CC         Evidence={ECO:0000250|UniProtKB:Q9QXW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71824;
CC         Evidence={ECO:0000250|UniProtKB:Q9QXW9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-histidine(in) + L-phenylalanine(out) = L-histidine(out) + L-
CC         phenylalanine(in); Xref=Rhea:RHEA:71003, ChEBI:CHEBI:57595,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-phenylalanine(out) + L-tryptophan(in) = L-phenylalanine(in)
CC         + L-tryptophan(out); Xref=Rhea:RHEA:71007, ChEBI:CHEBI:57912,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-isoleucine(in) + L-phenylalanine(out) = L-isoleucine(out) +
CC         L-phenylalanine(in); Xref=Rhea:RHEA:71011, ChEBI:CHEBI:58045,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-phenylalanine(out) + L-valine(in) = L-phenylalanine(in) + L-
CC         valine(out); Xref=Rhea:RHEA:71019, ChEBI:CHEBI:57762,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-leucine(in) + L-phenylalanine(out) = L-leucine(out) + L-
CC         phenylalanine(in); Xref=Rhea:RHEA:71023, ChEBI:CHEBI:57427,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutamine(in) + L-phenylalanine(out) = L-glutamine(out) + L-
CC         phenylalanine(in); Xref=Rhea:RHEA:71027, ChEBI:CHEBI:58095,
CC         ChEBI:CHEBI:58359; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-cysteine(in) + L-phenylalanine(out) = L-cysteine(out) + L-
CC         phenylalanine(in); Xref=Rhea:RHEA:71031, ChEBI:CHEBI:35235,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-methionine(in) + L-phenylalanine(out) = L-methionine(out) +
CC         L-phenylalanine(in); Xref=Rhea:RHEA:71039, ChEBI:CHEBI:57844,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-leucine(out) + L-methionine(in) = L-leucine(in) + L-
CC         methionine(out); Xref=Rhea:RHEA:71051, ChEBI:CHEBI:57427,
CC         ChEBI:CHEBI:57844; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-cysteine(out) + L-methionine(in) = L-cysteine(in) + L-
CC         methionine(out); Xref=Rhea:RHEA:71055, ChEBI:CHEBI:35235,
CC         ChEBI:CHEBI:57844; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-methionine(in) + S-methylmercury-L-cysteine(out) = L-
CC         methionine(out) + S-methylmercury-L-cysteine(in);
CC         Xref=Rhea:RHEA:71103, ChEBI:CHEBI:57844, ChEBI:CHEBI:190186;
CC         Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-leucine(out) + S-methylmercury-L-cysteine(in) = L-
CC         leucine(in) + S-methylmercury-L-cysteine(out); Xref=Rhea:RHEA:71107,
CC         ChEBI:CHEBI:57427, ChEBI:CHEBI:190186;
CC         Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-phenylalanine(out) + S-methylmercury-L-cysteine(in) = L-
CC         phenylalanine(in) + S-methylmercury-L-cysteine(out);
CC         Xref=Rhea:RHEA:71111, ChEBI:CHEBI:58095, ChEBI:CHEBI:190186;
CC         Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-phenylalanine(out) + L-serine(in) = L-phenylalanine(in) + L-
CC         serine(out); Xref=Rhea:RHEA:71035, ChEBI:CHEBI:33384,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycine(in) + L-phenylalanine(out) = glycine(out) + L-
CC         phenylalanine(in); Xref=Rhea:RHEA:71047, ChEBI:CHEBI:57305,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-alanine(in) + L-phenylalanine(out) = L-alanine(out) + L-
CC         phenylalanine(in); Xref=Rhea:RHEA:71043, ChEBI:CHEBI:57972,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q9UHI5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3,3',5-triiodo-L-thyronine(out) = 3,3',5-triiodo-L-
CC         thyronine(in); Xref=Rhea:RHEA:71811, ChEBI:CHEBI:533015;
CC         Evidence={ECO:0000250|UniProtKB:Q9QXW9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71812;
CC         Evidence={ECO:0000250|UniProtKB:Q9QXW9};
CC   -!- ACTIVITY REGULATION: Leucine transport activity is inhibited by 2-
CC       amino-bicyclo-(2,2,1)-heptane-2-carboxylate (BCH), glycine, L-isomers
CC       of the neutral amino acids and histidine.
CC       {ECO:0000269|PubMed:10391916}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=119 uM for L-leucine {ECO:0000269|PubMed:10391916};
CC         KM=265 uM for glycine {ECO:0000269|PubMed:10391916};
CC         KM=187 uM for L-alanine {ECO:0000269|PubMed:10391916};
CC         KM=116 uM for L-serine {ECO:0000269|PubMed:10391916};
CC         KM=68.6 uM for L-threonine {ECO:0000269|PubMed:10391916};
CC         KM=109 uM for L-cysteine {ECO:0000269|PubMed:10391916};
CC         KM=80.7 uM for L-asparagine {ECO:0000269|PubMed:10391916};
CC         KM=151 uM for L-glutamine {ECO:0000269|PubMed:10391916};
CC         KM=96.7 uM for L-isoleucine {ECO:0000269|PubMed:10391916};
CC         KM=124 uM for L-valine {ECO:0000269|PubMed:10391916};
CC         KM=204 uM for L-methionine {ECO:0000269|PubMed:10391916};
CC         KM=45 uM for L-phenylalanine {ECO:0000269|PubMed:10391916};
CC         KM=35.9 uM for L-tyrosine {ECO:0000269|PubMed:10391916};
CC         KM=57.6 uM for L-tryptophan {ECO:0000269|PubMed:10391916};
CC         KM=29.3 uM for L-DOPA {ECO:0000269|PubMed:15200428};
CC         KM=181 uM for L-histidine {ECO:0000269|PubMed:10391916};
CC       pH dependence:
CC         Optimum pH is 6.25. {ECO:0000269|PubMed:10391916};
CC   -!- SUBUNIT: Disulfide-linked heterodimer composed of the catalytic light
CC       chain subunit SLC7A8 and the heavy chain subunit SLC3A2
CC       (PubMed:10391916). SLC3A2 acts as a chaperone for correct plasma
CC       membrane trafficking and stabilization of SLC7A8 and modulates the
CC       substrate affinity and specificity of SLC7A8. ICAM-1 associates with
CC       the heterodimer SLC3A2/SLC7A8; facilitates leucine uptake (By
CC       similarity). {ECO:0000250|UniProtKB:Q9UHI5,
CC       ECO:0000269|PubMed:10391916}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9UHI5};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:Q9UHI5}. Basolateral
CC       cell membrane {ECO:0000269|PubMed:16027961}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q9UHI5}. Note=Localized to the plasma
CC       membrane when coexpressed with SLC3A2/4F2hc. Colocalized with
CC       SLC3A2/4F2hc at the basolateral membrane of kidney cortex proximal
CC       tubules and small intestine epithelia of the villi.
CC       {ECO:0000250|UniProtKB:Q9UHI5}.
CC   -!- TISSUE SPECIFICITY: Expression is seen in jejunum mucosa and the
CC       epithelial cells of the jejunum, ileum and colon, as well as in kidney,
CC       placenta, brain, testis and skeletal muscle. Expressed in retina, inner
CC       blood-retinal barrier of retina, retinal vascular endothelial cells.
CC       Also expressed in the intestinal epithelial cell line IEC-6 and in the
CC       retinal capillary endothelial cell line TR-iBRB2.
CC       {ECO:0000269|PubMed:10391916, ECO:0000269|PubMed:15980244,
CC       ECO:0000269|PubMed:16027961}.
CC   -!- SIMILARITY: Belongs to the amino acid-polyamine-organocation (APC)
CC       superfamily. L-type amino acid transporter (LAT) (TC 2.A.3.8) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB024400; BAA82517.1; -; mRNA.
DR   RefSeq; NP_445894.1; NM_053442.1.
DR   AlphaFoldDB; Q9WVR6; -.
DR   SMR; Q9WVR6; -.
DR   STRING; 10116.ENSRNOP00000019618; -.
DR   TCDB; 2.A.3.8.6; the amino acid-polyamine-organocation (apc) family.
DR   iPTMnet; Q9WVR6; -.
DR   PhosphoSitePlus; Q9WVR6; -.
DR   PaxDb; 10116-ENSRNOP00000019618; -.
DR   Ensembl; ENSRNOT00000019618.5; ENSRNOP00000019618.3; ENSRNOG00000014311.6.
DR   Ensembl; ENSRNOT00055020572; ENSRNOP00055016570; ENSRNOG00055012104.
DR   Ensembl; ENSRNOT00060044749; ENSRNOP00060037100; ENSRNOG00060025856.
DR   Ensembl; ENSRNOT00065054154; ENSRNOP00065044567; ENSRNOG00065031419.
DR   GeneID; 84551; -.
DR   KEGG; rno:84551; -.
DR   UCSC; RGD:619904; rat.
DR   AGR; RGD:619904; -.
DR   CTD; 23428; -.
DR   RGD; 619904; Slc7a8.
DR   eggNOG; KOG1287; Eukaryota.
DR   GeneTree; ENSGT00940000158278; -.
DR   InParanoid; Q9WVR6; -.
DR   OMA; WVSNAAL; -.
DR   OrthoDB; 1103451at2759; -.
DR   PhylomeDB; Q9WVR6; -.
DR   TreeFam; TF313355; -.
DR   Reactome; R-RNO-210991; Basigin interactions.
DR   Reactome; R-RNO-352230; Amino acid transport across the plasma membrane.
DR   SABIO-RK; Q9WVR6; -.
DR   PRO; PR:Q9WVR6; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Bgee; ENSRNOG00000014311; Expressed in ovary and 19 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0031528; C:microvillus membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015297; F:antiporter activity; ISO:RGD.
DR   GO; GO:0015187; F:glycine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015180; F:L-alanine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015179; F:L-amino acid transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015190; F:L-leucine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015175; F:neutral L-amino acid transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015101; F:organic cation transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0015349; F:thyroid hormone transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0019534; F:toxin transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0089718; P:amino acid import across plasma membrane; ISO:RGD.
DR   GO; GO:0003333; P:amino acid transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006865; P:amino acid transport; ISO:RGD.
DR   GO; GO:0015816; P:glycine transport; ISO:RGD.
DR   GO; GO:1904273; P:L-alanine import across plasma membrane; ISO:RGD.
DR   GO; GO:0015807; P:L-amino acid transport; ISO:RGD.
DR   GO; GO:1903801; P:L-leucine import across plasma membrane; ISO:RGD.
DR   GO; GO:0015820; P:L-leucine transport; ISO:RGD.
DR   GO; GO:0015804; P:neutral amino acid transport; ISS:UniProtKB.
DR   GO; GO:0035524; P:proline transmembrane transport; ISO:RGD.
DR   GO; GO:0070327; P:thyroid hormone transport; ISS:UniProtKB.
DR   GO; GO:0015827; P:tryptophan transport; ISO:RGD.
DR   GO; GO:0015829; P:valine transport; ISO:RGD.
DR   Gene3D; 1.20.1740.10; Amino acid/polyamine transporter I; 1.
DR   InterPro; IPR002293; AA/rel_permease1.
DR   InterPro; IPR050598; AminoAcid_Transporter.
DR   InterPro; IPR004760; L_AA_transporter.
DR   NCBIfam; TIGR00911; 2A0308; 1.
DR   PANTHER; PTHR11785; AMINO ACID TRANSPORTER; 1.
DR   PANTHER; PTHR11785:SF113; LARGE NEUTRAL AMINO ACIDS TRANSPORTER SMALL SUBUNIT 2; 1.
DR   Pfam; PF13520; AA_permease_2; 1.
DR   PIRSF; PIRSF006060; AA_transporter; 1.
PE   1: Evidence at protein level;
KW   Amino-acid transport; Antiport; Cell membrane; Disulfide bond; Membrane;
KW   Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..533
FT                   /note="Large neutral amino acids transporter small subunit
FT                   2"
FT                   /id="PRO_0000054275"
FT   TOPO_DOM        1..45
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        46..66
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        67..74
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        75..96
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        97..117
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        118..150
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        151..158
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        159..179
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        180..182
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        183..211
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        212..231
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        232..253
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        254..266
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        267..288
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        289..313
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        314..339
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        340..365
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        366..383
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        384..387
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        388..409
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        410..424
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        425..447
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TRANSMEM        448..467
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   TOPO_DOM        468..533
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          500..533
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..22
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         54
FT                   /ligand="L-leucine"
FT                   /ligand_id="ChEBI:CHEBI:57427"
FT                   /ligand_note="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   BINDING         135
FT                   /ligand="L-tryptophan"
FT                   /ligand_id="ChEBI:CHEBI:57912"
FT                   /ligand_note="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   BINDING         247
FT                   /ligand="L-leucine"
FT                   /ligand_id="ChEBI:CHEBI:57427"
FT                   /ligand_note="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   BINDING         396
FT                   /ligand="L-tryptophan"
FT                   /ligand_id="ChEBI:CHEBI:57912"
FT                   /ligand_note="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   SITE            135
FT                   /note="Important for substrate specificity"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   SITE            247
FT                   /note="Important for substrate specificity"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXW9"
FT   MOD_RES         23
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         529
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   DISULFID        155
FT                   /note="Interchain (with C-103 in SLC3A2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UHI5"
SQ   SEQUENCE   533 AA;  58190 MW;  99479DB60DA69DF0 CRC64;
     MEKGTRQRNN TAKNHPDRGS DTSPEAEASS GGGGVALKKE IGLVSACGII VGNIIGSGIF
     VSPKGVLENA GSVGLALIVW IVTGVITAVG ALCYAELGVT IPKSGGDYSY VKDIFGGLAG
     FLRLWIAVLV IYPTNQAVIA LTFSNYVLQP LFPTCFPPES GLRLLAAICL LLLTWVNCSS
     VRWATRVQDI FTAGKLLALA LIIIMGVVQI CKGEFFWLEP KNAFENFQEP DIGLVALAFL
     QGSFAYGGWN FLNYVTEELV DPYKNLPRAI FISIPLVTFV YVFANIAYVT AMSPQELLAS
     NAVAVTFGEK LLGVMAWIMP ISVALSTFGG VNGSLFTSSR LFFAGAREGH LPSVLAMIHV
     KRCTPIPALL FTCLSTLLML VTSDMYTLIN YVGFINYLFY GVTVAGQIVL RWKKPDIPRP
     IKISLLFPII YLLFWAFLLI FSLWSEPVVC GIGLAIMLTG VPVYFLGVYW QHKPKCFNDF
     IESLTLVSQK MCVVVYPQEG DSGTEETIDD VEEQHKPIFQ PTPVKDPDSE EQP
//
